Chung, A. H., Leisner, T. M., Dardis, G. J., Bivins, M. M., Keller, A. L., & Parise, L. V. (2019). CIB1 depletion with docetaxel or TRAIL enhances triple-negative breast cancer cell death. Cancer Cell Int.
Citação norma ChicagoChung, Alexander H., Tina M. Leisner, Gabrielle J. Dardis, Marissa M. Bivins, Alana L. Keller, and Leslie V. Parise. "CIB1 Depletion With Docetaxel or TRAIL Enhances Triple-negative Breast Cancer Cell Death." Cancer Cell Int 2019.
MLA citiranjeChung, Alexander H., et al. "CIB1 Depletion With Docetaxel or TRAIL Enhances Triple-negative Breast Cancer Cell Death." Cancer Cell Int 2019.
Opozorilo: Ti citati niso vedno 100% točni.